PuSH - Publication Server of Helmholtz Zentrum München: Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose 800 mg after progression on 400 mg.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Zalcberg, J.R.* ; Verweij, J.* ; Casali, P.G.* ; Le Cesne, A.* ; Reichardt, P.* ; Blay, J.-Y.* ; Schlemmer, M. ; van Glabbeke, M.* ; Brown, M.* ; Judson, I.R.*

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose 800 mg after progression on 400 mg.

Eur. J. Cancer 41, 1751-1757 (2005)

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords imatinib; GIST; dose effects; progression

ISSN (print) / ISBN 0959-8049

e-ISSN 1879-0852

Journal European Journal of Cancer

Quellenangaben Volume: 41, Pages: 1751-1757

Publisher Elsevier

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) CCG Tumor Therapy with Hyperthermia (IMI-KTH)